Anti-CD22 antibodies
US9856323B2 · kind B2 · utility
7Cited by
1References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 2013 |
| Grant date | Jan 2, 2018 |
| Priority date | — |
| Expiry date | Feb 14, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Anti-CD22 antibodies, including isolated nucleic acids that encode at least one such anti-CD22 antibody, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including therapeutic compositions, methods and devices.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.